| Financial Year |
March 31 2023 |
| Monetary Funds |
330,295,005.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
33,776,057.22 |
| Accounts Receivable |
658,138,280.41 |
| Advances to Suppliers |
30,795,436.05 |
| Other Receivables |
222,690,436.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,555,916.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,456,087.77 |
| Other Current Assets |
73,424,005.10 |
| Total Current Assets |
2,983,875,217.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
186,164,428.15 |
| Long-term Equity Investment |
118,523,444.45 |
| Investment Properties |
46,457,601.36 |
| Fixed Assetes |
524,511,280.29 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
740,844,165.81 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
856,270.39 |
| Deferred Income Tax Assets |
181,223,129.55 |
| Other Non-Current Assets |
54,151,297.82 |
| Sub-Total of Non-Current Assets |
1,863,956,124.73 |
| Total Assets |
4,847,831,342.22 |
| Short-Term Loans |
1,367,333,630.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
15,772,262.49 |
| Accounts Payable |
1,303,743,572.95 |
| Accounts Received In Advance |
3,289,317.18 |
| Employee Compensation Payable |
11,824,019.84 |
| Taxes Payable |
3,455,038.49 |
| Interest Payable |
-- |
| Dividend Payable |
145,205.33 |
| Other payables |
13,062,603.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
50,997,178.44 |
| Other Current Liabilities |
178,570,032.70 |
| Sub-Total of Current Liabilities |
3,082,878,579.45 |
| Long-term Loans |
788,464,741.97 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
18,765,175.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
854,767,374.61 |
| Total Liabilities |
3,937,645,954.06 |
| Paid-In Capital(Or Share Stock) |
595,960,158.00 |
| Capital Surplus |
239,520,535.04 |
| Surplus Reserve |
63,317,927.42 |
| LESS:Treasury Stock |
119,628.78 |
| Undistributed Profits |
-29,697,581.34 |
| Minority Stockholder's Interest |
41,203,977.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
868,981,410.34 |
| Owner's Equity（Stockholder's Equity） |
910,185,388.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,847,831,342.22 |
